Latest Clinical News

Manage Adverse Effects Associated With Navitoclax in Patients With Myelofibrosis

12 hours ago

Thrombocytopenia was the most common adverse effect, which was managed through dose reduction.

Expert: The Great Migration of Hematology, Oncology Pharmacists Brings a Call to Action for the Field

12 hours ago

Zahra Mahmoudjafari, PharmD, BCOP, DPLA; Alison Gulbis, PharmD, BCOP; and Kamakshi Rao, PharmD, BCOP, FASHP, discuss research conducted looking to assess the hematology-oncology pharmacist “great migration” from the field.

Clinical Overview: Isotretinoin (Absorica) for Severe Recalcitrant Nodular Acne

13 hours ago

Isotretinoin exerts dose-dependent inhibition of sebaceous gland function, thereby reducing sebum secretion, which is associated with improvement in nodular acne.

Implications of Legislation Passed in the House That Places Restrictions on FDA Accelerated Approval Pathway for Cancer, Rare Disease Drug Pipeline

14 hours ago

Ken Thorpe, PhD, professor of public health at Emory University and chairman of Partnership to Fight Chronic Disease, discusses legislation that the US House of Representatives recently passed to put greater restrictions on the FDA’s accelerated approval pathway.

Ofatumumab Shows Long-Term Improvements in Multiple Sclerosis Disease Activity

15 hours ago

After 4 years of treatment with ofatumumab, 78.8% of patients with relapsing forms of multiple sclerosis who continuously received ofatumumab achieved NEDA-3 compared to 51.8% of those who switched from teriflunomide to ofatumumab.